Chief Scientific Officer at Nuclea Biotechnologies
目前就职：CSO and General Manager - Nuclea Diagnostics
职业概述：
Since 1997, Walter Carney have been the Head of the
Oncogene Science organization, which functions as a
center of Oncology Excellence for Siemens Dx. Oncogene
Science develops, manufactures and distributes oncology
biomarker products. I have published over 250 articles
and abstracts, have been awarded over 25 patents and
have numerous pending patent applications. In addition
to being the inventor of the circulating HER-2/neu
protein test, he has been a leader in integrating the
FDA cleared test into the clinical management of women
with HER-2 Positive Breast Cancer. Since 1997, Walter
Carney have been the Head of the Oncogene Science
organization, which functions as a center of Oncology
Excellence for Siemens Dx. Oncogene Science develops,
manufactures and distributes oncology biomarker products.
He has published over 250 articles and abstracts, have been
awarded over 25 patents and have numerous pending patent
applications. In addition to being the inventor of the
circulating HER-2/neu protein test, he has been a leader
in integrating the FDA cleared test into the clinical
management of women with HER-2 Positive Breast Cancer.
